baylor-college-of-medicine

(3)
Legend
Wei-Wu He
Founder · Investor · Executive

Wei-Wu He

Wei-Wu He is a scientist, inventor, entrepreneur and investor who serves as Executive Chairman and CEO of Human Longevity, Inc., the San Francisco Bay Area precision-health company that pairs whole-genome sequencing with advanced imaging and blood analytics to catch age-related disease early. Trained as a molecular biologist at Baylor College of Medicine with an MBA from Wharton, he was among the first scientists at Human Genome Sciences before building OriGene Technologies into a major research-tools business. Over three decades he has founded or funded dozens of biotech companies through his venture fund Emerging Technology Partners, and he now channels that experience into the science of extending healthy human lifespan.

wei-wu-he · human-longevityRead →
Legend
Tatiana Fofanova
Founder · Executive · Scientist

Tatiana Fofanova

Tatiana Fofanova is the co-founder and CEO of Koda Health, a Houston-based B2B enterprise SaaS company that helps health systems and payers scale advance care planning. Trained as a molecular-medicine PhD at Baylor College of Medicine and a former HHMI scholar, she left bench and pediatric work after concluding that patients needed access and good information more than newer drugs. She built Koda out of the Texas Medical Center's Biodesign Fellowship in 2020 with co-founders Desh Mohan and Katelin Cherry, describing the product as 'TurboTax meets Duolingo' for the hardest conversations in medicine. The company now supports more than a million patients nationwide and raised an oversubscribed $7M Series A in October 2025.

tatiana-fofanova · koda-healthRead →
Legend
James Lu
Founder · Executive · Scientist

James Lu

James Lu is the co-founder and CEO of Helix, a population genomics company he helped launch in 2015 with Justin Kao and Scott Burke. An MD/PhD trained at Baylor College of Medicine with chemical engineering degrees from Stanford, Lu built his career at the intersection of machine learning, electronic health records, and genetics. He argues that the genome should sit alongside blood pressure and cholesterol as a core clinical input - the difference being that your genome never changes. Under his leadership Helix runs one of the largest clinical sequencing labs in the US and the Helix Research Network, and its GenoSphere dataset links more than 500,000 clinico-genomic records.

james-lu · helixRead →